28 April, 2022
Nanexa AB (publ) today announced that the European Patent Office (EPO) has granted the company’s patent application relating to the drug delivery system PharmaShell®. The patent protection covers the manufacturing method of PharmaShell and products produced using the method.
20 April, 2022
Positive development in the product projects and in the patent portfolio
2 maj, 2022
Aktiespararna, Aktiedagen Stockholm
20 mars, 2022